KPC Pharmaceuticals (SHSE:600422) FFO


SHSE:600422 KPC Pharmaceuticals Inc SHSE:600422
62 GF Score
Price ¥8.22
GF Value ¥11.77
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is KPC Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:600422
62GF Score
KPC Pharmaceuticals Inc SHSE:600422
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is KPC Pharmaceuticals (SHSE:600422) Overvalued in 2026?

Based on GuruFocus' analysis, KPC Pharmaceuticals stock appears to be undervalued. The current stock price of ¥8.22 is trading 30.2% below its estimated GF Value™ of ¥11.77. GuruFocus considers KPC Pharmaceuticals to be Significantly Undervalued.

Key valuation signals for SHSE:600422:

  • FFO:
  • GF Value™: ¥11.77 vs. price of ¥8.22 (30.2% below fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the SHSE:600422 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KPC Pharmaceuticals Business Description

Address No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
62GF Score

Get the complete analysis for SHSE:600422

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.22
Price
¥11.77
GF Value